![EMJ Neurology 8 [Supplement 2] 2020 Front Cover](https://emj.emg-health.com/wp-content/uploads/sites/2/2020/12/EMJ-Neurology-8-Supplement-2-2020-Front-Cover.jpg)
In this supplement to EMJ Neurology, two leading experts in multiple sclerosis (MS), Prof Tjalf Ziemssen and Prof Diego Centonze, explored the sphingosine 1-phosphate (S1P) receptor modulators drug class and how they can be utilised in the management of patients with MS.
Latest articles
All articles
18 Mins
27
Jan
New Advances in the Treatment of Duchenne Muscular Dystrophy and Spinal Muscular Atrophy
Both spinal muscular atrophy (SMA) and Duchenne muscular dystrophy (DMD) are monogenic neuromuscular diseases, which cause progressive proximal-to-distal muscular weakness, leading to loss of motor function and related pulmonary and musculoskeletal co-morbidities and reduced survival.